We met President Obama on His Birthday in Chicago IL at the Cultural...
Prompted in part by a case involving a Chicago surgeon, the Food and Drug Administration is proposing stricter rules about redesigned medical devices, saying many should undergo more scrutiny before being implanted in patients.
Insider Selling: Robert W.A. Sellers Unloads 1,650 Shares of Edwards Lifesciences Corp. Stock
Edwards Lifesciences Corp. VP Robert W.A. Sellers sold 1,650 shares of the company's stock on the open market in a transaction dated Thursday, March 6th.
The Motley Fool
Medtronic Wins European Patent Fight Against Edwards
The company announced today that the European Patent Office has invalidated and revoked a patent, the Spenser, held by Edwards Lifesciences for an aortic valve replacement system.
Northland Securities Increases Edwards Lifesciences Corp. Price Target to $90.00
Northland Securities' price objective suggests a potential upside of 24.12% from the stock's previous close.
The Washington Post
U.S. Stocks Rise for Third Day After Confidence Data
U.S. stocks rose for a third day amid improving U.S. consumer confidence and speculation that the Federal Reserve will continue to support the economy.
The Motley Fool
Can Abbott Laboratories Beat Baxter International and Edwards Lifesciences in 2014?
However, Abbott Laboratories was not the only Healthcare Equipment stock to be handsomely beaten by the S&P 500.
Jim Cramer's 'Mad Money' CEO Chats: Edwards Lifesciences and Galena Biopharma
Your browser is not supported. Please upgrade to one of the following browsers: Google Chrome Mozilla Firefox Apple Safari Microsoft Internet Explorer 8+ You may proceed to the site by clicking here , however some pages might not work correctly.
Medical Device/Diagnostic Ind.
Medtronic Learns From Edwards Lifesciences Errors in TAVR Launch
Medtronic is launching its CoreValve transcatheter aortic valve replacement device roughly two years behind Edwards' Sapien device.